You just read:

Abbott Announces 10-Year Data Evaluating HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis

News provided by

Abbott

06 Jun, 2012, 06:10 BST